BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 9573010)

  • 1. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
    Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
    Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
    Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
    J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.
    Chin H; Nakamura N; Kamiyama R; Miyasaka N; Ihle JN; Miura O
    Blood; 1996 Dec; 88(12):4415-25. PubMed ID: 8977232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
    Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
    Yoon D; Watowich SS
    Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
    Sawyer ST; Penta K
    J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
    Sakamoto H; Kitamura T; Yoshimura A
    J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.
    Li K; Miller C; Hegde S; Wojchowski D
    J Biol Chem; 2003 Oct; 278(42):40702-9. PubMed ID: 12909618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
    Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
    Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
    Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
    Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
    Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
    Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y; Senda H; Noda M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.
    Wakao H; Harada N; Kitamura T; Mui AL; Miyajima A
    EMBO J; 1995 Jun; 14(11):2527-35. PubMed ID: 7781605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.